CLINICAL TRIALS AND OBSERVATIONS The association of reduced folate carrier 80G A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number
نویسندگان
چکیده
1Division of Clinical Pharmacology, Department of Medicine and Care, Faculty of Health Sciences, Linköping, Sweden; 2Division of Molecular Genetic Diagnostics, Department of Clinical Biochemistry, University of Copenhagen, Copenhagen, Denmark; 3The Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark; 4Department of Clinical Pharmacology, Bispebjerg Hospital, Copenhagen, Denmark; 5Department of Pediatrics, University Hospitals in Rigshospitalet, Copenhagen, Denmark; 6Department of Pediatrics, University Hospitals in Rigshospitalet, Skejby, Denmark; 7Department of Pediatrics, University Hospitals in Rigshospitalet, Aalborg, Denmark; 8Department of Pediatrics, University Hospitals in Rigshospitalet, Odense, Denmark; and 9Institute of Gynecology, Obstetrics, and Pediatrics, The Medical Faculty, University of Copenhagen, Copenhagen, Denmark
منابع مشابه
CLINICAL TRIALS AND OBSERVATIONS Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia
Methotrexate polyglutamates (MTXPGs) determine in vivo efficacy in acute lymphoblastic leukemia (ALL). MTXPG accumulation differs by leukemic subtypes, but genomic determinants of MTXPG variation in ALL remain unclear. We analyzed 3 types of whole genome variation: leukemia cell gene expression and somatic copy number variation, and inherited single nucleotide polymorphism (SNP) genotypes and d...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Twenty-five–year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study
1Department of Pediatrics, University of Michigan, Ann Arbor; 2School of Public Health, University of Alberta, Edmonton, AB; 3Department of Biostatistics, The Fred Hutchinson Cancer Research Center, Seattle, WA; 4Department of Pediatrics, Dana-Farber Cancer Institute, Boston, MA; 5Departments of Pediatrics and Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; 6Department of Epidem...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Early molecular response to posttransplantation imatinib determines outcome in MRD Philadelphia-positive acute lymphoblastic leukemia (Ph ALL)
In adult Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph ALL), minimal residual disease (MRD) after stem cell transplantation (SCT) is associated with a relapse probability exceeding 90%. Starting imatinib in the setting of MRD may decrease this high relapse rate. In this prospective multicenter study, 27 Ph ALL patients received imatinib upon detection of MRD after SCT. Bcr-a...
متن کاملCLINICAL TRIALS AND OBSERVATIONS A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia
1Yale University School of Medicine and Yale Cancer Center, New Haven, CT; 2Texas Children’s Cancer Center, Houston, and National Institute of Mental Health, Rockville, MD; 3University of Washington School of Medicine, Seattle; 4David Geffen School of Medicine at University of California, Los Angeles; 5Yale Center for Clinical Investigation, New Haven, CT; 6Children’s Oncology Group Operations ...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMAALL 0288 randomized study
The GIMEMA ALL 0288 trial was designed to evaluate the impact of a 7-day prednisone (PDN) pretreatment on complete remission (CR) achievement and length, the influence of the addition of cyclophosphamide (random I) to a conventional 4-drug induction on CR rate and duration, and whether an early post-CR intensification (random II) by an 8-drug consolidation could improve CR duration. Median foll...
متن کامل